Trifirò, Gianluca http://orcid.org/0000-0003-1147-7296
Gini, Rosa
Barone-Adesi, Francesco
Beghi, Ettore
Cantarutti, Anna
Capuano, Annalisa
Carnovale, Carla
Clavenna, Antonio
Dellagiovanna, Mirosa
Ferrajolo, Carmen
Franchi, Matteo
Ingrasciotta, Ylenia
Kirchmayer, Ursula
Lapi, Francesco
Leone, Roberto
Leoni, Olivia
Lucenteforte, Ersilia
Moretti, Ugo
Mugelli, Alessandro
Naldi, Luigi
Poluzzi, Elisabetta
Rafaniello, Concita
Rea, Federico
Sultana, Janet
Tettamanti, Mauro
Traversa, Giuseppe
Vannacci, Alfredo
Mantovani, Lorenzo
Corrao, Giovanni
Article History
First Online: 29 September 2018
Compliance with ethical standards
:
: No sources of funding were used to assist in the preparation of this study.
: Annalisa Capuano, Anna Cantarutti, Antonio Clavenna, Alessandro Mugelli, Alfredo Vannacci, Carla Carnovale, Carmen Ferrajolo, Concita Rafaniello, Francesco Barone-Adesi, Janet Sultana, Ersilia Lucenteforte, Elisabetta Poluzzi, Federico Rea, Giuseppe Traversa, Lorenzo Mantovani, Luigi Naldi, Mirosa Dellagiovanna, Matteo Franchi, Mauro Tettamanti, Olivia Leoni, Roberto Leone, Ursula Kirchmayer, Ugo Moretti and Ylenia Ingrasciotta have no conflicts of interest that are directly relevant to the content of this study. Ettore Beghi has received grants from UCB Pharma and the Italian Ministry of Health unrelated to the present paper; he has also received consulting fees from UCB Pharma unrelated to the present paper. Francesco Lapi has provided consultancies on epidemiology research and data analysis for Angelini, IBSA, Bayer, Novartis, GSK and Alfasigma unrelated to the present paper. Giovanni Corrao has received research support from the European Community (EC), AIFA and the Italian Ministry for University and Research (MIUR) and participated in a variety of projects that were funded by pharmaceutical companies (i.e. Novartis, GSK, Roche, AMGEN and BMS) unrelated to the present paper; he has also received honoraria as an advisory board member of Roche unrelated to the present paper. Gianluca Trifirò has participated in advisory boards on biosimilars organised by Sandoz and Hospira unrelated to the present paper; furthermore, he coordinates a pharmacoepidemiology research team at the University of Messina, which receives research grants for projects that are not related to the present paper. Rosa Gini is employed by the Agenzia Regionale di Sanità della Toscana, an organization belonging to the Tuscany region, which has access to the type of data whose strengths and limitations are described in this manuscript and which participates in proposals for grants and contracts to conduct studies using such data.
: No ethical approval was required for the preparation of this review.
Free to read: This content has been made available to all.